HZN-457 / Arrowhead, Amgen - LARVOL DELTA

Study to Evaluate HZN-457 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=36 | Completed | Sponsor: Horizon Therapeutics Ireland DAC | Active, not recruiting ➔ Completed | N=56 ➔ 36 | Trial completion date: Mar 2024 ➔ Aug 2023 | Trial primary completion date: Mar 2024 ➔ Aug 2023

Enrollment change • Trial completion • Trial completion date • Trial primary completion date

Study to Evaluate HZN-457 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=56 | Active, not recruiting | Sponsor: Horizon Therapeutics Ireland DAC | Recruiting ➔ Active, not recruiting

Enrollment closed